Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Breast Cancer
•
Radiation Oncology
In the absence of other risk factors, do you treat the regional lymph nodes in triple negative breast cancer?
Or for that matter, offer PMRT on the basis of a patient having triple negative disease?
Answer from: Radiation Oncologist at Community Practice
At present I don't, but once Canadian and EORTC studies are published with full details available, it may change practice patterns.
Sign in or Register to read more
415
Related Questions
In what clinical scenario, if any, would you consider APBI appropriate treatment for a patient with triple-negative breast cancer?
What are your top takeaways from SABCS 2023?
Would you offer PMRT to a young patient with a remote history of mantle/lung RT for Hodgkins lymphoma and a left cT0N1 triple positive breast cancer with a complete response after neoadjuvant chemotherapy?
What criteria do you use to determine the utility of DIBH for breast cancer patients?
What percentage of your breast cancer patients do you plan using IMRT vs 3D?
How do you manage moderate chest wall pain after breast radiation if imaging studies are normal?
What fields would you treat for a postmastectomy patient with a single suspected small IMN node on MRI but no other criteria for PMRT and a negative SNB?
Would you ever considering de-escalating therapy in any way for women with inflammatory breast cancer who had a complete pathologic response after surgery?
What rates of breast (not arm) lymphedema would you quote to patients post-lumpectomy and adjuvant radiation?
Do young, early-stage breast cancer patients with pCR to chemoimmunotherapy still benefit from PMRT?